TMC Acquisition recalls
TMC Acquisition has 52 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 20 Jul 2022. 52 are still ongoing. The most frequent reason is sterility.
Total recalls52since 2022
Last 12 months0reported
Class I00% of total
Ongoing52latest 20 Jul 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 52 100%Class III 0 0%
Why tmc acquisition is recalled
Product types
By year
Ongoing tmc acquisition recalls
52 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Methylene Blue Hypotonic Solution, 10mg/mL, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Enanthate 100/100mg/ml, a)-vial recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Sermorelin/Glycine 2000mcg/5mg/mL-vial, Refrigerate recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Biotin 5mg/mL-vial, Refrigerate, Tailor Made Compounding recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Hydroxocobalamin Preservative Free 5mg/mL-vial, Refrigerate recalled | TMC Acquisition | Sterility | Nationwide |
| Drug | CLASS II | Hydroxocobalamin 25mg/mL-vial, Room Temperature recalled | TMC Acquisition | Sterility | Nationwide |
All tmc acquisition recalls, newest first
52 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.